We are testing the usability of a health information website that shares easy-to-understand information about prostate cancer. The website is called iPICS. We want to see if the website is helpful for people living in rural areas, especially older adults. By working with public libraries, we hope to learn how to make the website better and easier to use. Our goal is to help people find trustworthy health information so they can make good decisions about their health.

Are you a patient with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)? If so this could be the study for you. The purpose of this study is to investigate if the sonrotoclax in combination with obinutuzumab or rituximab works better and is safe in participants with

We're doing this study to explore how a device called TheraBionic affects people with liver cancer and their condition. This device uses special frequencies to target cancer cells and is being tested for treating advanced liver cancer.

The purpose of this immunotherapy study is to compare two different chemotherapy treatments administered before breast cancer surgery to see which has the better outcome.

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

Have you been diagnosed with Gastric Cancer? If so, you might be able to take part in a study to see if an investigational product is safe and effective for treating Gastric Cancer.

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

The purpose of this study is to see at what doses of etentamig combined with Iberdomide is better tolerated and safe for patients with relapsed/refractory multiple myeloma.